|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.09 CAD | -10.00% |
|
-.--% | -.--% |
AREV Life Sciences Global Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was CAD 0.16937 million compared to CAD 0.510094 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.09M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
AREV LIFE SCIENCES GLOBAL CORP. 
